The genetic architecture of common diseases is central to the scientific and clinical goals of human genetics because it directly impacts biology, disease screening, diagnosis, prognosis and treatment ...

That is not the story’s end: Dr. Sharp co-founded Biogen, Alnylam Pharmaceuticals, and Magen Biosciences – firms that develop drugs for diseases like multiple sclerosis. As an entrepreneur, he ...